Functional effects of interleukin 31 in human primary keratinocytes

被引:86
作者
Kasraie, S. [1 ]
Niebuhr, M. [1 ]
Baumert, K. [1 ]
Werfel, T. [1 ]
机构
[1] Hannover Med Sch, Dept Dermatol & Allergy, Div Immunodermatol & Allergy Res, D-30449 Hannover, Germany
关键词
atopic dermatitis; human primary keratinocytes; IFN-gamma; IL-31; IL-31R; Pam3Cys; ATOPIC SKIN INFLAMMATION; EPITHELIAL-CELLS; EPIDERMAL-KERATINOCYTES; T-CELLS; IL-31; RECEPTOR; DERMATITIS; EXPRESSION; CYTOKINE; MACROPHAGES; ACTIVATION;
D O I
10.1111/j.1398-9995.2011.02545.x
中图分类号
R392 [医学免疫学];
学科分类号
100108 [医学免疫学];
摘要
P>Background: Interleukin (IL)-31 is a T-cell cytokine acting through a heterodimeric receptor composed of IL-31RA and OSMR which is expressed on epithelial cells including keratinocytes. A major function of IL-31 in atopic dermatitis (AD) is the induction of pruritus in the skin. Inflammatory effects of IL-31 in human primary keratinocytes (HPKs) still remain unclear. We investigated expression, regulation of the IL-31 receptor as well as functions of IL-31 in HPKs. Methods: Human primary keratinocytes were stimulated with TLR-2 ligands (Pam3Cys, lipoteichoic acid and peptidoglycan), or Th1 and Th2 associated cytokines (IFN-gamma and IL-4), respectively. IL-31R expression and regulation as well as functional effects of IL-31 stimulation were then investigated at both the mRNA and protein level and compared with HPKs from patients with AD. The STAT signalling pathway and TLR-2 expression were investigated using Western blot and Immunohistochemical stainings, respectively. Results: Pam3Cys or IFN-gamma significantly up-regulated IL-31RA and OSMR expression. IL-31 activated STAT-3 phosphorylation in HPKs which was augmented after preactivation with Pam3Cys or IFN-gamma. IL-31 enhanced the secretion of CCL2 after up-regulation of the receptor with Pam3Cys or IFN-gamma. However, this was not observed in keratinocytes from AD patients where an impaired TLR-2 expression was found. Conclusions: Together, our findings show a functional role of IL-31 in HPKs and provide a new link between TLR-2 ligands and IL-31 which might be dysregulated in AD. Altered function of IL-31 may have implications for cutaneous inflammation in eczema where skin colonization with Staphylococcus aureus and dysregulation of TLR-2 have been described.
引用
收藏
页码:845 / 852
页数:8
相关论文
共 40 条
[1]
IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis [J].
Bilsborough, J ;
Leung, DYM ;
Maurer, M ;
Howell, M ;
Boguniewcz, M ;
Yao, L ;
Storey, H ;
LeCiel, C ;
Harder, B ;
Gross, JA .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (02) :418-425
[2]
Interleukin-31 and oncostatin-M mediate distinct signaling reactions and response patterns in lung epithelial cells [J].
Chattopadhyay, Souvik ;
Tracy, Erin ;
Liang, Ping ;
Robledo, Olivier ;
Rose-John, Stefan ;
Baumann, Heinz .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (05) :3014-3026
[3]
Activation of human eosinophils and epidermal keratinocytes by Th2 cytokine IL-31: implication for the immunopathogenesis of atopic dermatitis [J].
Cheung, Phyllis Fung-Yi ;
Wong, Chun-Kwok ;
Ho, Amy Wing-Yin ;
Hu, Shuiqing ;
Chen, Da-Peng ;
Lam, Christopher Wai-Kei .
INTERNATIONAL IMMUNOLOGY, 2010, 22 (06) :453-467
[4]
Association between increased CCL2 (MCP-1) expression in lesions and persistence of disease activity in giant-cell arteritis [J].
Cid, M. C. ;
Hoffman, M. P. ;
Hernandez-Rodriguez, J. ;
Segarra, M. ;
Elkin, M. ;
Sanchez, M. ;
Vilardell, C. ;
Garcia-Martinez, A. ;
Pla-Campo, M. ;
Grau, J. M. ;
Kleinman, H. K. .
RHEUMATOLOGY, 2006, 45 (11) :1356-1363
[5]
Interleukin 31 mediates MAP kinase and STAT1/3 activation in intestinal epithelial cells and its expression is upregulated in inflammatory bowel disease [J].
Dambacher, Julia ;
Beigel, Florian ;
Seiderer, Julia ;
Haller, Dirk ;
Goeke, Burkhard ;
Auernhammer, Christoph J. ;
Brand, Stephan .
GUT, 2007, 56 (09) :1257-1265
[6]
Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice [J].
Dillon, SR ;
Sprecher, C ;
Hammond, A ;
Bilsborough, J ;
Rosenfeld-Franklin, M ;
Presnell, SR ;
Haugen, HS ;
Maurer, M ;
Harder, B ;
Johnston, J ;
Bort, S ;
Mudri, S ;
Kuijper, JL ;
Bukowski, T ;
Shea, P ;
Dong, DL ;
Dasovich, M ;
Grant, FJ ;
Lockwood, L ;
Levin, SD ;
LeCiel, C ;
Waggie, K ;
Day, H ;
Topouzis, S ;
Kramer, J ;
Kuestner, R ;
Chen, Z ;
Foster, D ;
Parrish-Novak, J ;
Gross, JA .
NATURE IMMUNOLOGY, 2004, 5 (07) :752-760
[7]
Molecular and functional characterization of a soluble form of oncostatin M/interleukin-31 shared receptor [J].
Diveu, Caroline ;
Venereau, Emilie ;
Froger, Josy ;
Ravon, Elisa ;
Grimaud, Linda ;
Rousseau, Franccis ;
Chevalier, Sylvie ;
Gascan, Hugues .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (48) :36673-36682
[8]
Quality of life in atopic dermatitis - Discussion [J].
Leung, DYM ;
Finlay, AY .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2001, 45 (01) :S66-S66
[9]
Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2 [J].
Girardin, SE ;
Travassos, LH ;
Hervé, M ;
Blanot, D ;
Boneca, IG ;
Philpott, DJ ;
Sansonetti, PJ ;
Mengin-Lecreulx, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (43) :41702-41708
[10]
Itch: More than skin deep [J].
Greaves, MW ;
Khalifa, N .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2004, 135 (02) :166-172